Aspiriant LLC’s Intel INTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $566K | Buy |
12,828
+669
| +6% | +$30.7K | 0.02% | 205 |
|
|
2025
Q4 | $449K | Buy |
12,159
+12
| +0.1% | +$453 | 0.01% | 229 |
|
|
2025
Q3 | $408K | Sell |
12,147
-5,070
| -29% | -$123K | 0.01% | 219 |
|
|
2025
Q2 | $386K | Buy |
17,217
+4,335
| +34% | +$89.8K | 0.01% | 229 |
|
|
2025
Q1 | $293K | Sell |
12,882
-9,092
| -41% | -$199K | 0.01% | 240 |
|
|
2024
Q4 | $441K | Sell |
21,974
-5,922
| -21% | -$133K | 0.02% | 200 |
|
|
2024
Q3 | $654K | Buy |
27,896
+5,128
| +23% | +$128K | 0.02% | 172 |
|
|
2024
Q2 | $705K | Sell |
22,768
-3,456
| -13% | -$113K | 0.03% | 171 |
|
|
2024
Q1 | $1.16M | Sell |
26,224
-439
| -2% | -$19.6K | 0.05% | 137 |
|
|
2023
Q4 | $1.34M | Sell |
26,663
-519
| -2% | -$21.1K | 0.06% | 119 |
|
|
2023
Q3 | $966K | Sell |
27,182
-56
| -0.2% | -$1.95K | 0.05% | 136 |
|
|
2023
Q2 | $911K | Buy |
27,238
+2,114
| +8% | +$66.4K | 0.05% | 142 |
|
|
2023
Q1 | $821K | Buy |
25,124
+498
| +2% | +$14.1K | 0.04% | 146 |
|
|
2022
Q4 | $651K | Buy |
24,626
+801
| +3% | +$22.2K | 0.03% | 159 |
|
|
2022
Q3 | $614K | Sell |
23,825
-1,200
| -5% | -$40.9K | 0.03% | 154 |
|
|
2022
Q2 | $932K | Sell |
25,025
-646
| -3% | -$27.9K | 0.05% | 126 |
|
|
2022
Q1 | $1.27M | Buy |
25,671
+2,486
| +11% | +$123K | 0.07% | 117 |
|
|
2021
Q4 | $1.19M | Buy |
23,185
+4,876
| +27% | +$249K | 0.06% | 121 |
|
|
2021
Q3 | $978K | Sell |
18,309
-186
| -1% | -$10.1K | 0.06% | 121 |
|
|
2021
Q2 | $1.04M | Buy |
18,495
+150
| +0.8% | +$8.8K | 0.06% | 112 |
|
|
2021
Q1 | $1.18M | Sell |
18,345
-53
| -0.3% | -$3.16K | 0.08% | 92 |
|
|
2020
Q4 | $915K | Sell |
18,398
-57,614
| -76% | -$2.81M | 0.06% | 107 |
|
|
2020
Q3 | $3.94M | Buy |
76,012
+57,391
| +308% | +$2.98M | 0.31% | 42 |
|
|
2020
Q2 | $1.11M | Sell |
18,621
-1,546
| -8% | -$92.4K | 0.1% | 75 |
|
|
2020
Q1 | $1.09M | Buy |
20,167
+1,626
| +9% | +$96.2K | 0.11% | 76 |
|
|
2019
Q4 | $1.11M | Sell |
18,541
-145
| -0.8% | -$8.11K | 0.1% | 90 |
|
|
2019
Q3 | $960K | Sell |
18,686
-333
| -2% | -$16.4K | 0.09% | 110 |
|
|
2019
Q2 | $910K | Sell |
19,019
-798
| -4% | -$39.6K | 0.08% | 116 |
|
|
2019
Q1 | $1.06M | Sell |
19,817
-4,959
| -20% | -$252K | 0.09% | 106 |
|
|
2018
Q4 | $1.16M | Sell |
24,776
-1,293
| -5% | -$60.5K | 0.09% | 99 |
|
|
2018
Q3 | $1.23M | Sell |
26,069
-2,528
| -9% | -$123K | 0.11% | 100 |
|
|
2018
Q2 | $1.42M | Sell |
28,597
-708
| -2% | -$37.6K | 0.12% | 92 |
|
|
2018
Q1 | $1.53M | Buy |
+29,305
| New | +$1.39M | 0.13% | 81 |
|
|
2017
Q4 | – | Sell |
-36,143
| Closed | -$1.38M | – | 128 |
|
|
2017
Q3 | $1.38M | Sell |
36,143
-9,869
| -21% | -$351K | 0.12% | 91 |
|
|
2017
Q2 | $1.55M | Sell |
46,012
-2,072
| -4% | -$74.1K | 0.14% | 87 |
|
|
2017
Q1 | $1.73M | Sell |
48,084
-5,837
| -11% | -$211K | 0.15% | 87 |
|
|
2016
Q4 | $1.96M | Sell |
53,921
-12,181
| -18% | -$436K | 0.18% | 77 |
|
|
2016
Q3 | $2.5M | Sell |
66,102
-48,381
| -42% | -$1.71M | 0.25% | 58 |
|
|
2016
Q2 | $3.49M | Sell |
114,483
-1,554
| -1% | -$48.7K | 0.33% | 53 |
|
|
2016
Q1 | $3.75M | Buy |
+116,037
| New | +$3.56M | 0.36% | 43 |
|
Other funds holding INTC
VCM
NC
VPM
Aspiriant LLC's INTC Position: Q1 2026 in Review
Aspiriant LLC increased its Intel (INTC) stake by 5.5% in Q1 2026, buying an estimated $30.7K and bringing the position to 12,828 shares worth $566K. The position accounts for 0.02% of the portfolio, ranked #205.
Aspiriant LLC first reported a position in INTC in Q1 2016 and has held it in 40 quarters since. The position peaked at $3.94M in Q3 2020. 2,568 funds tracked by Wall St. Rank hold INTC as of Q1 2026.
- Aspiriant LLC held 12,828 shares of Intel worth $566K as of Q1 2026.
- Aspiriant LLC bought 669 Intel shares in Q1 2026, an estimated $30.7K.
- Intel made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #205 holding.
- Aspiriant LLC first reported a position in Intel in Q1 2016 and has held it in 40 quarters since.
- Aspiriant LLC's Intel position peaked at $3.94M in Q3 2020.
- 2,568 funds tracked by Wall St. Rank held Intel as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.